Sublingual immunotherapy not effective in house dust mite-allergic children in primary care
Pediatric Allergy and Immunology, 10/24/2011De Bot CMA et al.
Sublingual immunotherapy with house dust mite allergen was not better than placebo in reducing rhinitis symptoms in house dust mite–allergic children in primary care. SLIT as administered in this study can be considered safe.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.